These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12164553)

  • 1. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione.
    LoPachin RM; Ross JF; Reid ML; Das S; Mansukhani S; Lehning EJ
    Neurotoxicology; 2002 May; 23(1):95-110. PubMed ID: 12164553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of acrylamide and 2,5-hexanedione in rats evaluated using a functional observational battery and pathological examination.
    Shell L; Rozum M; Jortner BS; Ehrich M
    Neurotoxicol Teratol; 1992; 14(4):273-83. PubMed ID: 1522832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.
    Lehning EJ; Balaban CD; Ross JF; LoPachi RM
    Neurotoxicology; 2002 Sep; 23(3):415-29. PubMed ID: 12387367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione.
    Sickles DW
    Toxicol Appl Pharmacol; 1991 May; 108(3):390-6. PubMed ID: 2020966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic neuropathies: Mechanistic insights based on a chemical perspective.
    LoPachin RM; Gavin T
    Neurosci Lett; 2015 Jun; 596():78-83. PubMed ID: 25218479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrylamide neuropathy. I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum.
    Lehning EJ; Balaban CD; Ross JF; Reid MA; LoPachin RM
    Neurotoxicology; 2002 Sep; 23(3):397-414. PubMed ID: 12387366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of toxicities of acrylamide and 2,5-hexanedione in hens and rats on 3-week dosing regimens.
    Jortner BS; Ehrich M
    J Toxicol Environ Health; 1993 Aug; 39(4):417-28. PubMed ID: 8345530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-Diketone central neuropathy: quantitative analyses of cytoskeletal components in myelinated axons of the rat rubrospinal tract.
    Lopachin RM; Jortner BS; Reid ML; Monir A
    Neurotoxicology; 2005 Dec; 26(6):1021-30. PubMed ID: 15964632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining toxic distal axonopathies.
    LoPachin RM
    Toxicol Lett; 2000 Mar; 112-113():23-33. PubMed ID: 10720709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots.
    LoPachin RM; Jortner BS; Reid ML; Das S
    Toxicol Appl Pharmacol; 2003 Nov; 193(1):29-46. PubMed ID: 14613714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neurotoxicity screening battery for use in safety evaluation: effects of acrylamide and 3',3'-iminodipropionitrile.
    Schulze GE; Boysen BG
    Fundam Appl Toxicol; 1991 Apr; 16(3):602-15. PubMed ID: 1842897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: video-enhanced differential interference microscopy in peripheral nervous system axons.
    Stone JD; Peterson AP; Eyer J; Oblak TG; Sickles DW
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):50-8. PubMed ID: 10558923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrylamide intoxication modifies in vitro responses of peripheral nerve axons to anoxia.
    Lehning EJ; Gaughan CL; LoPachin RM
    J Peripher Nerv Syst; 1997; 2(2):165-74. PubMed ID: 10959230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.
    Lehning EJ; Dyer KS; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):58-66. PubMed ID: 7482540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.
    Lehning EJ; Balaban CD; Ross JF; LoPachin RM
    Neurotoxicology; 2003 Jan; 24(1):109-23. PubMed ID: 12564387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 2,5-hexanedione and acrylamide on myosin heavy chain isoforms of slow and fast skeletal muscles of the rat.
    Oishi Y; Yamamoto H; Nagano M; Miyamoto E; Futatsuka M
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):15-21. PubMed ID: 8685898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. IV. In vitro analysis of transport following acrylamide and 2,5-hexanedione.
    Sickles DW
    Toxicol Lett; 1992 Jul; 61(2-3):199-204. PubMed ID: 1641866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of acrylamide-induced neurotoxicity in diabetic rats.
    Al Deeb S; Al Moutaery K; Arshaduddin M; Biary N; Tariq M
    Neurotoxicol Teratol; 2000; 22(2):247-53. PubMed ID: 10758354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of modification and degradation of neurofilament proteins in rats subchronically treated with allyl chloride, acrylamide, or 2,5-hexanedione.
    Nagano M; Yamamoto H; Harada K; Miyamoto E; Futatsuka M
    Environ Res; 1993 Nov; 63(2):229-40. PubMed ID: 8243417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrylamide axonopathy revisited.
    LoPachin RM; Balaban CD; Ross JF
    Toxicol Appl Pharmacol; 2003 May; 188(3):135-53. PubMed ID: 12729714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.